Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts. during the Ross operation

被引:75
作者
da Costa, FDA
Dohmen, PM
Duarte, D
von Glenn, C
Lopes, SV
Haggi, H
da Costa, MBA
Konertz, W
机构
[1] PUCPr, CV Surg, BR-82200120 Curitiba, Parana, Brazil
[2] Humboldt Univ, Charite Hosp, Berlin, Germany
关键词
allograft heart valve; humoral immune response; short-term valve function;
D O I
10.1016/j.ejcts.2004.12.057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Compare the immunological and echocardiographic data of decellularized versus cryopreserved allografts used for RVOT reconstruction during Ross operation. Methods: From 16/01/03 thru 07/10/03, 20 Ross operations were performed using decellularized (n=11) or cryopreserved (n=9) allografts. Echocardiography was done at discharge, 1, 3, 6 and 12 months and annually thereafter. Samples for determination of antibodies against HLA class I and II were obtained preoperatively and at days 5, 10, 30, 90 and 180 postoperatively. These samples were tested by the ELISA method in LAT-M dishes (unspecific) for identification of circulating antibodies and the results expressed as mean sample values (Is= DO/cutoff). If positive, LAT-E (specific) was performed and PRA levels determined. Results: There was no mortality. Cryopreserved allografts showed marked Is values elevations for class I and II antibodies which started at the first month and remained elevated up to 6 months. In contrast, of the patients receiving decellularized allografts, seven remained negative, two patients had only marginal elevation of class I antibodies and two patients showed abnormal elevations of PRA levels. This response happened earlier than in the cryopreserved group, starting on the 5th postoperative day and has returned to baseline levels in one case. Echocardiography showed mild, but significant, elevation of gradients in cryopreserved valves but none in the decellularized. Conclusions: Decellularized allografts had normal function up to 18 months and showed important reduction of the immunogenic response when compared to cryopreserved valves. (c) 2005 Published by Elsevier B.V.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 25 条
[1]   The immunogenicity of the extracellular matrix in arterial xenografts [J].
Allaire, E ;
Bruneval, P ;
Mandet, C ;
Becquemin, JP ;
Michel, JB .
SURGERY, 1997, 122 (01) :73-81
[2]   Valve interstitial cells induce donor-specific T-cell anergy [J].
Batten, P ;
McCormack, AM ;
Rose, ML ;
Yacoub, MH .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (01) :129-135
[3]  
Bechtel JFM, 2003, J HEART VALVE DIS, V12, P734
[4]  
Chambers JC, 1997, CIRCULATION, V96, P2206
[5]   Blood group incompatibility and accelerated homograft fibrocalcifications [J].
Christenson, JT ;
Vala, D ;
Sierra, J ;
Beghetti, M ;
Kalangos, A .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (01) :242-250
[6]   Comparison of cryopreserved homografts and decellularized porcine heterografts implanted in sheep [J].
da Costa, FDA ;
Dohmen, PM ;
Lopes, SV ;
Lacerda, G ;
Pohl, F ;
Vilani, R ;
da Costa, MBA ;
Vieira, ED ;
Yoschi, S ;
Konertz, W ;
da Costa, IA .
ARTIFICIAL ORGANS, 2004, 28 (04) :366-370
[7]  
Dignan R, 2000, J HEART VALVE DIS, V9, P504
[8]   Ross operation with a tissue-engineered heart valve [J].
Dohmen, PM ;
Lembcke, A ;
Hotz, H ;
Kivelitz, D ;
Konertz, WF .
ANNALS OF THORACIC SURGERY, 2002, 74 (05) :1438-1442
[9]  
Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P87
[10]  
Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P82